Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).
Bossard, N;
Velten, M;
Remontet, L;
Belot, A;
Maarouf, N;
Bouvier, AM;
Guizard, AV;
Tretarre, B;
Launoy, G;
Colonna, M;
+14 more...Danzon, A;
Molinie, F;
Troussard, X;
Bourdon-Raverdy, N;
Carli, PM;
Jaffré, A;
Bessaguet, C;
Sauleau, E;
Schvartz, C;
Arveux, P;
Maynadié, M;
Grosclaude, P;
Estève, J;
Faivre, J;
(2007)
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).
European journal of cancer (Oxford, England, 43 (1).
pp. 149-160.
ISSN 0959-8049
DOI: https://doi.org/10.1016/j.ejca.2006.07.021
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
We present the main results of the first population-based cancers survival study gathering all French registry data. Survival data on 205,562 cancer cases diagnosed between 01/01/1989 and 31/12/1997 were analysed. Relative survival was estimated using an excess rate model. The evolution of the excess mortality rate over the follow-up period was graphed. The analysis emphasised the effect of age at diagnosis and its variation with time after diagnosis. For breast and prostate cancers, the age-standardised five-year relative survivals were 84% and 77%, respectively. The corresponding results in men and women were 56% versus 58% for colorectal cancer and 12% versus 16% for lung cancer. For some cancer sites, the excess mortality rate decreased to low values by five years after diagnosis. For most cancer sites, age at diagnosis was a negative prognostic factor but this effect was often limited to the first year after diagnosis.
